EXOZ

eXoZymes, Inc. EXOZ

EXOZ
eXoZymes, Inc. ANEB
Anebulo Pharmaceuticals, Inc. MGX
Metagenomi, Inc. Common Stock QNCX
Quince Therapeutics, Inc. SRZN
Surrozen, Inc. MGNX
MacroGenics, Inc. ZNTL
Zentalis Pharmaceuticals, Inc. ENTX
Entera Bio Ltd. ATYR
aTyr Pharma, Inc. CNTB
Connect Biopharma Holdings Limited

Net profit

EBITDA

P/E Ratio

Capitalization

Performance

Periode EXOZ ANEB MGX QNCX SRZN MGNX ZNTL ENTX ATYR CNTB
6M 13.31 % 142.31 % 125.00 % 93.00 % 41.67 % 43.22 % 23.81 % 36.93 % -66.89 % 120.48 %
YTD -14.92 % 59.49 % -12.14 % 2.66 % -4.56 % -48.79 % -48.00 % 7.11 % -74.42 % 51.24 %
1Y 45.66 % 33.33 % 67.34 % 135.65 % 29.52 % -58.98 % -47.65 % 31.69 % -63.24 % 46.40 %
3Y 45.66 % -3.08 % -67.70 % 78.70 % -60.75 % -57.32 % -93.43 % 193.19 % -42.20 % 99.13 %
5Y 45.66 % -64.51 % -67.70 % -96.10 % -91.03 % -93.08 % -96.29 % 117.12 % -42.20 % -90.10 %
10Y 45.66 % -64.51 % -67.70 % -94.13 % -91.03 % -93.50 % -93.28 % -61.62 % -42.20 % -90.10 %
From the beginning 45.66 % -64.51 % -67.70 % -94.13 % -91.03 % -93.24 % -93.28 % -61.62 % -42.20 % -90.10 %

Dividend